BioMarin Pharmaceutical Inc. Stock News

While the data looks good so far, the duo's treatment is behind a similar BioMarin therapy in the testing and approval process.

The Nasdaq leads with a small gain in late-afternoon trade. Indexes are holding in a tight, bullish range. Will these restaurant plays keep rising?

Four years on, BioMarin’s hemophilia A gene therapy is still going strong—it staved off bleeding episodes in patients with hemophilia A and reduced their reliance on infusions of a blood-clotting

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Intuitive Surgical (ISRG

Pfizer Inc and Sangamo Therapeutics Inc said on Thursday their gene therapy helped maintain levels of a vital protein for up to 14 months in patients with a rare genetic disorder in which blood does n

Pfizer Inc and Sangamo Therapeutics Inc said on Thursday their gene therapy helped maintain levels of a vital protein for up to 14 months in patients with a rare genetic disorder in which blood does n

Pfizer Inc and Sangamo Therapeutics Inc said on Thursday their gene therapy helped maintain levels of a vital protein for up to 14 months in patients with a rare genetic disorder in which blood does n

There’s a pivotal trial in the offing for Pfizer and Sangamo’s hemophilia A gene therapy, but, in the meantime, the duo is unveiling updated phase 1/2 data. The highest dose of the treatment helpe

In mice, they can eliminate the cells partly responsible for many diseases of aging, researchers report. In other news: hemophilia gene therapy and concerns over AbbVie-Allergan merger.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Armata Pharmaceuticals

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) * Adverum Biotechnologies Inc (NASDAQ: ADVM) * Affim

BioMarin Pharmaceutical (NASDAQ:BMRN)‘s stock had its “buy” rating restated by SunTrust Banks in a note issued to investors on Wednesday, TipRanks reports. They presently have a $109.00 price ob

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) Adverum Biotechnologies Inc...